Literature DB >> 7272619

Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders.

C Dé Montigny, F Grunberg, A Mayer, J P Deschenes.   

Abstract

Eight patients suffering from a major unipolar depression and having field to respond to treatment for three weeks or more with tricyclic antidepressants were given lithium. All eight patients experienced a remarkable relief of their depression within 48 hours. This rapid antidepressant effect of lithium in "treatment-resistant' patients might be due to the enhancement of the efficacy of the central serotoninergic system, unveiling the tricyclic antidepressant-induced sensitization of the serotoninergic postsynaptic receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272619     DOI: 10.1192/bjp.138.3.252

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  29 in total

1.  Lithium carbonate augmentation therapy in fibromyalgia.

Authors:  M A Tyber
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

2.  Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.

Authors:  Jos Prickaerts; Dieder Moechars; Kim Cryns; Ilse Lenaerts; Hansfried van Craenendonck; Ilse Goris; Guy Daneels; J Adriaan Bouwknecht; Thomas Steckler
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

3.  An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression.

Authors:  Jeremy Barowsky; Thomas L Schwartz
Journal:  Psychiatry (Edgmont)       Date:  2006-07

4.  Management of depression in general practice.

Authors:  S Brandon
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-01

Review 5.  Drug alternatives to lithium in manic-depressive disorders.

Authors:  D M Shaw
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

6.  Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects.

Authors:  L H Price; D S Charney; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  The Care of Patients With Complex Mood Disorders.

Authors:  Zachary A Cordner; Dean F MacKinnon; J Raymond DePaulo
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

Review 8.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

Review 9.  Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression.

Authors:  Chia-Ming Chang; Soichiro Sato; Changsu Han
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

10.  Augmentation treatment in major depressive disorder: focus on aripiprazole.

Authors:  J Craig Nelson; Andrei Pikalov; Robert M Berman
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.